The chief financial officer (CFO) at Tristel, Liz Dixon, has announced her intention to retire from the business on 30 June 2025, after almost two decades in the role.

The medical device decontamination provider said that the process to appoint a new CFO is underway and that it has been "pleased with the quality of candidates" showing an interest in the position.

Tristel added that it would make a further announcement in due course.

Dixon stated: "Whilst I am very sad to be leaving Tristel after nearly 18 years, I do so happy in the knowledge that the business is well placed both financially and commercially for its next stage of growth under the leadership of Matt Sassone and the senior team.

"It has been a great pleasure to have been part of an amazing UK success story, and to see Tristel establish a leading position in the global infection prevention world. I wish the incredible Tristel team the very best and am confident that they will continue to deliver to our shareholders."

Chief executive officer at Tristel, Matt Sassone, added: "Since Liz joined Tristel, the company has grown considerably, and Liz has played a pivotal role in that success. In addition to supporting the operational side of the business, she has been instrumental in driving our commercial performance and built a robust, capable finance team-ensuring we are well-positioned for the continued expansion we anticipate in the years ahead.

"It has been a pleasure to work with Liz over the last nine months, and I am grateful that due to her stewardship I have joined a business with a very strong financial position, and well-funded to deliver further organic commercial growth."

---